Member Info for Chelsea11

Well, both Next-Gen and ADC are done this month, with Oxford Global tomorrow and more to follow.

The commercial.enquires mailbox will be exploding 😂

Thunder, with respect, the Interim Results were only issued as recently as 30th Jan, so why not check those, rather than relying on 2nd hand info. Safer to do so for your investment surely?

Good debate on SC129 but it took a number of twists & turns away from the original point.

That was purely and simply when, or if, there might be a milestone payment if Genmab decide to take SC129 into the clinic. It wasn’t about what might or might not happen 5 years down the line and the stab in the dark $10M suggestion makes that crystal clear combined with the comment that such a payment would help underpin the SP, not send it into orbit.

Precisely Ray and obviously why they were able to say “on track”.

Violin - are you party then, to conversations between Genmab and Scancell?

Violin - “and LD didn't speak at the AGM as if Genmab was anyway near milestone payments”

From the January Interims RNS issued to the market:.

“Development of SC129, out licensed to Genmab, continues on track towards potential clinical development.”

On track will do for me.

Good to see store expansion strategy continuing. Effectively one store per month for the 5 month period and so reasonable to think another 5+ before calendar year end.

Hi Chester - yes, agree.

Who knows, we might even be blessed with one of Haribo’s rockets before the end of March.

#holdingstrong 🤣

Wonder how close we might be to news that Genmab will be taking SC129 into the clinic. It's already been discussed on here that if that happens, it would be a big surprise if contractually, that didn't trigger a further milestone payment. Stab in the dark $10M+ dollars at that point in time. Remember that Lindy was bullish about its prospects in the presentation complimenting the Interims.

That would be cool and underpin the SP for other newsflow anticipated this year. Just around the corner? Maybe!

For anyone who cares to look, there is some recent chat re. Modi-1 on the MacMillan Forum. I won’t post a link so that the choice to visit or not, is yours alone.

WTP - my take………

It’s broadly about paying someone to make sure regulatory submissions are faultless and delivered on time.

Pretty pointless surely, to waste money fulfilling that role, if there are zero plans on the table, to submit anything to regulators?

Unless perhaps you are fomophobic

Had to chuckle at the minimum package of 100 RNS per year.

Only 94 to go to make it cost-effective 🤣

As clearly stated below, the link works just fine if you copy and paste it whole.

Ah you’ll have to copy / paste the whole link, for it to work.

Naturally, the Abstract itself, is embargoed at this time.

Yup. Maybe this link helps.

https://www.abstractsonline.com/pp8/#!/20272/presentation/11402

Anyone tempted to email commercial.enquiries and enquire if any blockbuster commercial deals are imminent lol

EE - SCLC is Small Cell Lung Cancer which is the pipeline is I believe SC134.

Happy to be corrected if wrong.

Also TF, not sure why you branded my post as “optimism” . It’s all factual I believe based on recent RNS content and no attempt made from my side to predict anything.

All in the recent RNS for anyone to read but...............

Second stage of SCIB1 recruitment expected to complete by end of Q1 (don't know if on completion, that would generate a standalone RNS).

iSCIB+ recruitment has hopefully started, as announced.

Early data expected Q2 / Q3.

Worth saying again - no safety issues reported to this point in time. No RNS = great news.

Other news may be available ;-0

HAGW